Natco Pharma is investing an additional $14 million in eGenesis Inc., a US-based biotechnology company developing genetically engineered organs for human transplantation. The investment will be made through Natco Pharma’s wholly owned subsidiaries , NATCO Pharma (Canada) Inc., which will invest $9.5 million, and NATCO Pharma South Africa Proprietary Ltd, which will invest $4.5 million. […]